Quorum Sensing Contributes to Activated IgM-Secreting B Cell Homeostasis

Unité de Biologie des Populations Lymphocytaires, Départment d'Immunologie, Institut Pasteur, Paris 75015, France
The Journal of Immunology (Impact Factor: 4.92). 12/2012; 190(1). DOI: 10.4049/jimmunol.1200907
Source: PubMed


Maintenance of plasma IgM levels is critical for immune system function and homeostasis in humans and mice. However, the mechanisms that control homeostasis of the activated IgM-secreting B cells are unknown. After adoptive transfer into immune-deficient hosts, B lymphocytes expand poorly, but fully reconstitute the pool of natural IgM-secreting cells and circulating IgM levels. By using sequential cell transfers and B cell populations from several mutant mice, we were able to identify novel mechanisms regulating the size of the IgM-secreting B cell pool. Contrary to previous mechanisms described regulating homeostasis, which involve competition for the same niche by cells having overlapping survival requirements, homeostasis of the innate IgM-secreting B cell pool is also achieved when B cell populations are able to monitor the number of activated B cells by detecting their secreted products. Notably, B cell populations are able to assess the density of activated B cells by sensing their secreted IgG. This process involves the FcγRIIB, a low-affinity IgG receptor that is expressed on B cells and acts as a negative regulator of B cell activation, and its intracellular effector the inositol phosphatase SHIP. As a result of the engagement of this inhibitory pathway, the number of activated IgM-secreting B cells is kept under control. We hypothesize that malfunction of this quorum-sensing mechanism may lead to uncontrolled B cell activation and autoimmunity.

Download full-text


Available from: TAHIA D Fernández, Oct 06, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent progress has begun to reveal the often complex and changing roles of phosphotyrosine and phosphoinositide phosphatases in regulation of immunoreceptor signaling. The resultant confusion has been further increased by discoveries of new players. Here we provide a review of recent progress in defining the roles of these enzymes in immunoreceptor-dependent mast cell, T cell and B cell activation.
    No preview · Article · May 2013 · Current opinion in immunology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: B cell numbers and immunoglobulin (Ig) titers can increase several logs during immune responses. In contrast to this plasticity and despite constant renewal, B cell numbers are stable in absence of immunization. We assessed the role of serum Ig in maintaining specific B cell subsets homeostasis at steady state. Making use of mice genetically deficient in secreted IgM only (μS(-/-)), in switched Ig and hypermutated IgM (AID(-/-)) or fully agammaglobulemic (AID(-/-)μS(-/-)) we dissected the contribution of different Ig classes to four phenotypes associated with loss of serum Ig: i) increased splenic B cell numbers, mostly of the B1 and marginal zone (MZ) B cell subtypes, ii) enlarged germinal centers (GC) in spleen and mesenteric lymph nodes, iii) enrichment in IRF4(+)CD138(-) plasmablast-like cells, iv) overexpression of IgM in several cell subsets. Complementation experiments based either on mixed bone marrow reconstitution of chimeras or Ig infusion, and analysis of mice raised in germ-free conditions reveal a negative feedback mechanism in which MZ and B1 cells numbers are under the control of naturally secreted Ig as the result of an intrinsic property of the immune system, while GC development is under indirect control of secreted Ig that limit bacterial species triggering GC reactions.
    Full-text · Article · May 2013 · Blood
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effects of hyperthyroidism on B cell physiology are still poorly known. In this study, we evaluated the influence of high circulating levels of T3 on bone marrow, blood and spleen B cell subsets, more specifically on B cell differentiation to plasma cells, in C57BL/6 mice daily injected with T3 for fourteen days. As analyzed by flow cytometry, T3-treated mice exhibited increased frequencies of pre-B and immature B cells and decreased percentage of mature B cells in the bone marrow, accompanied by an increased frequency of blood B cells, splenic newly-formed B cells and total CD19+ B cells. T3 administration also promoted an increase in the size and cellularity of the spleen as well as in the white pulp areas of the organ, as evidenced by histological analyses. In addition, a decreased frequency of splenic B220+ cells correlating with an increased percentage of CD138+ plasma cells was observed in the spleen and bone marrow of T3-treated mice. Using ELIspot assay, an increased number of splenic immunoglobulin-secreting B cells from T3-treated mice was detected ex vivo. Similar results were observed in mice immunized with hen egg lysozyme and aluminum adjuvant alone or plus treatment with T3. In conclusion, we provide evidence that high circulating levels of T3 stimulate plasmacytogenesis favoring an increase of plasma cells in the bone marrow, a long-lived plasma cell survival niche. These findings suggest that a possible stimulatory effect on plasma cell differentiation could occur in untreated patients with Graves' disease.
    Full-text · Article · Dec 2013 · Journal of Endocrinology
Show more